Boehringer Ingelheim has announced an increase in sales for full year 2018, but a slight decline in profits, as price competition began to affect its biggest selling drug Spiriva. The German pharma's ...

As the EU patent expires on its flagship respiratory diseases product, Spiriva, Boehringer Ingelheim is looking to newer diabetes and respiratory drugs under the leadership of a new CEO. Formerly the ...

Drugs for Conditions A-Z ...

Allergy medicine may stop working because your body can become used to it. Allergies also might change over time. You might need to try a different medicine. Increasing the dose of your allergy ...